The weekly litigation news digest is live. Subscribe now

IP Verse

Abraxis Bioscience competitive analysis

Loading summary...

Latest patents of Abraxis Bioscience opposed by its competitors

Explore Abraxis Bioscience's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Nov 13, 2025
Patent NumberPublication DateTitleTotal Oppositions
EP2943192
Sep 29, 2021Methods Of Treating Pancreatic Cancer4
EP3248600
Jun 24, 2020Combinations And Modes Of Administration Of Therapeutic Agents And Combination Therapy2
EP2968254
Apr 22, 2020Methods Of Treating Lung Cancer1
EP2575803
Jul 26, 2017Methods Of Treating Bladder Cancer1

Latest PTAB cases involving Abraxis Bioscience

Discover the latest PTAB cases involving Abraxis Bioscience, highlighting their recent legal challenges and patent disputes.

Last updated on: Nov 17, 2025
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Abraxis Bioscience

IPR2018-00151Nov 9, 2017APOTEXABRAXIS BIOSCIENCETerminated
IPR2018-00152Nov 9, 2017APOTEXABRAXIS BIOSCIENCETerminated-Settled
IPR2018-00153Nov 9, 2017APOTEXABRAXIS BIOSCIENCESTerminated-Settled
IPR2018-00162Nov 9, 2017CIPLAABRAXIS BIOSCIENCESInstitution Denied
IPR2018-00163Nov 9, 2017CIPLAABRAXIS BIOSCIENCESInstitution Denied
IPR2017-01100Apr 4, 2017ACTAVISABRAXIS BIOSCIENCEInstitution Denied
IPR2017-01101Apr 4, 2017ACTAVISABRAXIS BIOSCIENCETerminated-Settled
IPR2017-01103Apr 4, 2017ACTAVISABRAXIS BIOSCIENCETerminated-Settled
IPR2017-01104Apr 4, 2017ACTAVISABRAXIS BIOSCIENCETerminated-Settled

Peer Comparison New

IP litigation analysis comparing Abraxis Bioscience with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Nov 13, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
ABRAXIS BIOSCIENCE - 8 - 6
ACTAVIS - - 5 -
GENERICS UK214 - - -
TEVA PHARMACEUTICALS20916 - 12